Cingulate Inc. (NASDAQ:CINGW) Short Interest Update

Cingulate Inc. (NASDAQ:CINGW) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 735 shares, a drop of 36.0% from the July 15th total of 1,149 shares. Based on an average daily volume of 11,063 shares, the short-interest ratio is presently 0.1 days.

Cingulate Price Performance

Shares of NASDAQ CINGW traded up $0.00 during mid-day trading on Wednesday, reaching $0.01. 5,500 shares of the company traded hands, compared to its average volume of 35,051. The stock has a fifty day simple moving average of $0.02 and a 200-day simple moving average of $0.03. Cingulate has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.